Asthma Control Among Patients Receiving Inhaled Corticosteroids in Thailand

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1210 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-05-31

Study Completion Date

2009-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the percentage of patients who has reached the GINA guideline of asthma treatment after receiving any inhaled corticosteroid for 3 months or longer in actual clinical practice. Such percentage for each level of severity - mild, moderate and severe persistent asthma as well as the differences of these rates will also be explored.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Asthma Inhaled corticosteroid Thai patient eligibility Persistent asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Established persistent asthma
* Currently treated with any inhaled corticosteroid therapy but not SYMBICORT nor SERETIDE for 3 months or longer

Exclusion Criteria

* Currently participating or have participated in a study with an investigational compound within the last 30 days
* Current diagnosis of chronic obstructive pulmonary disease (COPD)
* Smoked more than 10 packs a year

Minimum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

AstraZeneca (Thailand) Ltd.

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bandit Thinkhamrop, PhD

Role: PRINCIPAL_INVESTIGATOR

Department of Biostatistics and Demography, Faculty of Public Health, Khon Kaen University

Watchara Boonsawat, MD. PhD

Role: PRINCIPAL_INVESTIGATOR

Department of Medicine, Faculty of Medicine, Khon Kaen University

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-RTH-DUM-2008/1

Identifier Type: -

Identifier Source: org_study_id

Asthma Control Among Patients Receiving Inhaled Corticosteroids in Thailand

Study Results

Basic Information

Brief Summary

Detailed Description

Conditions

Keywords

Study Design

Eligibility Criteria

Inclusion Criteria

Exclusion Criteria

Sponsors

AstraZeneca

Responsible Party

Principal Investigators

Bandit Thinkhamrop, PhD

Watchara Boonsawat, MD. PhD

Locations

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Countries

Other Identifiers

NIS-RTH-DUM-2008/1